BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23830804)

  • 1. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.
    Pinto CA; Widodo E; Waltham M; Thompson EW
    Cancer Lett; 2013 Nov; 341(1):56-62. PubMed ID: 23830804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast-cancer stem cells-beyond semantics.
    Badve S; Nakshatri H
    Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stem cells: obstacles to therapy.
    Smalley M; Piggott L; Clarkson R
    Cancer Lett; 2013 Sep; 338(1):57-62. PubMed ID: 22554712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer stem cells: an update.
    Iqbal J; Chong PY; Tan PH
    J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
    Mallini P; Lennard T; Kirby J; Meeson A
    Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
    Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
    Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells: problems for therapy?
    Alison MR; Lim SM; Nicholson LJ
    J Pathol; 2011 Jan; 223(2):147-61. PubMed ID: 21125672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
    Dunning NL; Laversin SA; Miles AK; Rees RC
    Cancer Immunol Immunother; 2011 Aug; 60(8):1181-93. PubMed ID: 21688178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
    Leal JA; Lleonart ME
    Cancer Lett; 2013 Sep; 338(1):174-83. PubMed ID: 22554710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the cell of origin in breast cancer and breast cancer stem cells.
    Lindeman GJ; Visvader JE
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
    Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
    Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells in breast cancer and metastasis.
    Lawson JC; Blatch GL; Edkins AL
    Breast Cancer Res Treat; 2009 Nov; 118(2):241-54. PubMed ID: 19731012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
    Foroni C; Broggini M; Generali D; Damia G
    Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.
    Neelakantan D; Drasin DJ; Ford HL
    Cell Adh Migr; 2015; 9(4):265-76. PubMed ID: 25482627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].
    Yoshida GJ; Saya H
    Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.